GGTLC1 and metabolic dysfunction-associated steatotic liver disease: Gamma glutamyl transpeptidase (GGT) levels, one of main markers of NAFLD, were associated with cardiovascular disease and stroke, even in subjects with low or moderate cardiovascular risk [54].